Search our site 
 
Advanced Search
 
Home | Exam dates | Contact us | About us | Testimonials |
 
 

map
You are in Home >> Resources >> Pharmacology >> Local anaesthetics


Bupivacaine

Created: 18/7/2009
Updated: 19/11/2009
 

Bupivacaine is an amide local anaesthetic.


It is a clear, colourless solution prepared as a 0.25 and 0.5% (with or without epinephrine 1:200,000). For subarachnoid block, a 0.5% (heavy) solution containing 80 mg/ml glucose (specific gravity 1.026) is available.

The toxic dose of bupivacaine is 2 mg/kg (with or without epinephrine). It is one of the more cardiotoxic local anaesthetics. Bupivacaine is therefore contraindicated for i.v. regional anaesthesia (IVRA) because of potential risk of tourniquet failure and systemic absorption of the drug.

Bupivacaine may be administered by infiltration, intrathecally and epidurally. It is commonly used for epidural infusions (with or without an opioid) for labour and postoperatively.

Kinetics

Because of the pKa of 8.1, the onset of action is intermediate or slow. Bupivacaine is the most highly protein-bound (95%) amide local anaesthetic, which is the reason for its long duration of action. It is metabolised in the liver by N-dealkylation to pipecolylxylidine and pipecolic acid.


ArticleDate:20090718
SiteSection: Article
 
   
    
                                            
  Posting rules

     To view or add comments you must be a registered user and login  




Login Status  

You are not currently logged in.
UK/Ireland Registration
Overseas Registration

  Forgot your password?








 
All rights reserved © 2020. Designed by AnaesthesiaUK.

{Site map} {Site disclaimer} {Privacy Policy} {Terms and conditions}

 Like us on Facebook 

vp